News

Find News

Filter articles

Showing 2521 to 2530 of 2651 results

GE Healthcare accused of microscope patent infringement

US30-10-2013

A US company has filed a lawsuit against global healthcare company GE Healthcare , alleging it has infringed its patented microscope technology.

Bayer’s compulsory licence appeal set to start in India

India29-10-2013

A court appeal by Bayer against India’s first ever compulsory licence on its patented cancer drug will start today, October 29.

Californian governor vetoes biosimilars bill

US29-10-2013

The governor of California, Jerry Brown, has refused to sign legislation seeking to introduce changes to the state’s pharmacy law on biosimilars.

Arnold clears conflict of interest in SPC trial

UK28-10-2013

Mr Justice Arnold has refused to recuse himself from a patent trial after he was accused of being conflicted by an expert witness.

C.R. Bard secures $1 billion damages in patent victory

24-10-2013

The US District Court for the District of Arizona has rejected technology company W.L. Gore’s motion for a new trial to amend the judgment of its patent dispute with medical device maker C.R. Bard.

Hacon to fill Birss’s shoes at UK court

22-10-2013

British barrister Richard Hacon is set to become the permanent presiding judge of the Intellectual Property Enterprise Court, multiple sources have told WIPR.

AstraZeneca adds to cancer drug portfolio

UK18-10-2013

UK-based pharmaceutical company AstraZeneca announced on October 15 that its biologics R&D subsidiary MedImmune had acquired cancer drug maker Spirogen.

Radcliffe leaves Mayer Brown for Charles Russell

UK16-10-2013

Patent litigator Jonathan Radcliffe has left Mayer Brown to become partner at Charles Russell LLP.

Federal Circuit says no to “Prevail” trademark

16-10-2013

The US Court of Appeals for the Federal Circuit has denied a US company’s bid to trademark “Prevail” for medical devices used to treat obesity.

Bayer takes another swipe at Nexavar compulsory licence

India15-10-2013Legal developments

Bayer has appealed against the IPAB’s compulsory licence order that allows domestic generic maker Natco Pharma to market its own version of liver and kidney cancer drug Nexavar, this time at the Mumbai High Court.

Showing 2521 to 2530 of 2651 results

LSIPR